Power Law company profile

Onyx Pharmaceuticals

Biotech & Life Sciences · South San Francisco, United States · Founded 1992 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Headcount

100–500

Current team size

Unlock exact value

Investors

4 investors on Onyx Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Sequoia

Series B+ 3 investors entered at this stage

Federated Hermes

Domain Associates

OrbiMed

Patent intelligence

$105M patent portfolio · 38 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$105M

7.4× smaller than top peer BioNTech ($780M)

38 active patent families

Where Onyx Pharmaceuticals innovates Molecular biologyEnzyme inhibitionPeptideAziridineHeteroatom

Above peer median on Legal, Strategic, Market

Quality vs same-sector peers

Onyx Pharmaceuticals on the five Patsnap quality dimensions

Onyx Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Onyx Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Onyx Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Onyx Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo